Project Details
Description
A Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA (tolvaptan) 15, 30, or 60mg QD compared to Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Helpitalized with Dilutional H
Status | Finished |
---|---|
Effective start/end date | 10/30/12 → 10/31/14 |
Funding
- OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.